Loading…
Back To Schedule
Tuesday, June 16 • 9:30am - 10:30am
#215 L: ACTIV: A Public-Private Partnership to Speed COVID-19 Therapies and Vaccines

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-20-759-L04-P; CME 1.00; IACET 1.00; RN 1.00

The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership brings together senior leaders from the Foundation for the National Institutes of Health (FNIH), NIH, FDA, BARDA, CDC, EMA, and the pharmaceutical industry to advance vaccines and therapies for COVID-19. The goal for the ACTIV partnership is to develop a framework to prioritize vaccine and therapeutic candidates in development and connect clinical trial networks to test new and repurposed candidates. In this session, representatives from the NIH, BARDA, EMA, FDA, and industry will provide an overview of the activities that are being undertaken by the ACTIV partnership.

Learning Objectives

Describe how government and industry are collaborating to develop an international strategy for a coordinated research response to the COVID-19 pandemic; Discuss how a collaborative framework will prioritize vaccine and drug candidates, streamline clinical trials, coordinate regulatory processes, and/or leverage assets.

Chair

Robin M. Weinick, PhD

Speaker

FDA Update
Peter W. Marks, MD, PhD

Industry Update
Thomas Hudson, MD

FNIH Update
David Wholley, MA


Speakers
avatar for Thomas Hudson

Thomas Hudson

Senior Vice President, Research and Development, and Chief Scientific Officer, AbbVie
Thomas Hudson leads the company’s R&D organization and a global team of scientists who work across therapeutic areas to identify potential new treatments for a variety of diseases. Dr. Hudson leads R&D strategy for the company as well as providing leadership for the many scientific... Read More →
avatar for Robin Weinick

Robin Weinick

SVP/Managing Director Americas and Global Program Officer, DIA, United States
Robin M. Weinick, PhD. brings 25 years of experience to her DIA role as Senior Vice President & Managing Director, Americas, and Global Program Officer.Robin joins DIA from RTI International, a large, nonprofit research institute dedicated to improving the human condition. She also... Read More →
DW

David Wholley

Senior Vice President of Research Partnerships, Foundation for National Institutes of Health (FNIH)
David Wholley manages the Research Partnerships Division of the Foundation, which is responsible for major research collaborations including the Accelerating Medicines Partnership (AMP), the Biomarkers Consortium, the LungMAP precision medicine trial in lung cancer, and the Alzheimer’s... Read More →

Tuesday June 16, 2020 9:30am - 10:30am EDT
TBD Virtual Event Horsham, PA 19044
  09: Regulatory, Session
  • Featured Topics COVID 19 - Pandemic
  • Credit Type ACPE, CME, IACET, RN
  • Tags Session